Patent · US Active

Recombinant preparation of selected bromelain fractions

US8409840B2 · kind B2 · utility

7Cited by

2References

9Claims

0Family size

Assignee

URSAPHARM ARZNEIMITTEL GMBH · DE

Inventors

Rolf Muller · Marburg, DE
Nora Luniak · Saarburg, DE
Klaus Eschmann · Kleinblittersdorf, DE

Key dates

Filing date	Aug 8, 2008
Grant date	Apr 2, 2013
Priority date	—
Expiry date	Mar 15, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N15/815
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention pertains in general to Bromelain and particularly to the different active compounds contained in this complex mixture of proteins. The present invention provides recombinant expressed cysteine proteases, which are found in Bromelain. It has been found that the method for expression of the recombinant proteins is superior to the purification from Bromelain itself.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.